Pharmaceutical companies should have a market launch strategy at least two years before data from a registrational clinical trial is available.

HCP preferences have rapidly shifted towards remote and hybrid engagement. Cultural transformation, data silo elimination, and cross-functional collaboration are key to meeting these new demands through a successful omnichannel transition.

Pharmaceutical companies are likely to go digital in the next three-to-four years even with return of in-person engagements

Pharma companies should zero in on commonalities between functions to achieve a genuine customer-centric omnichannel